BioSpace News Archive

Arrayit Corporation signs allergy testing contracts with a consortium of medical clinics nationwide.

BioDelivery Sciences International, Inc. has appointed Thomas B. Smith, MD, FAAFP, as Chief Medical Officer and member of the Company’s Executive Leadership Team.

Response rate increases from 40% at 350 mg dose to approximately 70% at 525 mg

Rennova Health, Inc. its second rural hospital in Tennessee on June 1, 2018, announces today that on Friday July 27, 2018, JRMC started receiving payments from Medicare and other payers for services provided.

MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Tuesday, August 7, 2018, the Company will release its financial results for the quarter ended June 30, 2018. The Company’s management team will host a conference call discussing the Company’s financial results and recent corporate developments on Tuesday, August 7, 2018 at 4:30 pm (ET).

Nu-Med Plus, Inc. announces the launch of a new program to attain ISO 13485 certification.

Quartzy announced its plan to help labs across the United States save even more on supply shipments with free standard shipping for all orders over $99.

NewLink Genetics Corporation announced its clinical plan and strategy, reported consolidated financial results for the second quarter of 2018, and revised its cash guidance.

OmniSeq, Inc.® announced it is participating as a CLIA-certified/accredited laboratory for the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) precision medicine trial

RedHill Biopharma Ltd. today elaborated on the previously announced positive top-line results from the first Phase III study with orally-administered RHB-104 for Crohn’s disease (the MAP US study).